StockData
Disc Medicine, Inc. logo

Disc Medicine, Inc. (IRON) stock

IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$77.98+1.41 (+1.84%)

Close on Nov 18, 2026Market cap $2.99BP/E –Yield –

Disc Medicine operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Disc Medicine's operating cash flow for the twelve months ending Jun 30, 2026 was -$197.54M. For fiscal 2025 it was -$180.39M. The highest annual figure on record is -$27.53M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$180.39M–
FY2024Dec 31, 2024-$93.93M–
FY2023Dec 31, 2023-$73.46M–
FY2022Dec 31, 2022-$42.25M–
FY2021Dec 31, 2021-$27.53M–
FY2020Dec 31, 2020-$32.71M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$44.20M–
Q1 FY2026Mar 31, 2026-$62.24M–
Q4 FY2025Dec 31, 2025-$43.30M–
Q3 FY2025Sep 30, 2025-$47.80M–
Q2 FY2025Jun 30, 2025-$47.92M–
Q1 FY2025Mar 31, 2025-$41.38M–
Q4 FY2024Dec 31, 2024-$27.57M–
Q3 FY2024Sep 30, 2024-$17.36M–
Q2 FY2024Jun 30, 2024-$15.39M–
Q1 FY2024Mar 31, 2024-$33.60M–
Q4 FY2023Dec 31, 2023-$17.80M–
Q3 FY2023Sep 30, 2023-$7.48M–
Q2 FY2023Jun 30, 2023-$12.72M–
Q1 FY2023Mar 31, 2023-$35.47M–
Q4 FY2022Dec 31, 2022-$9.67M-149.6%
Q3 FY2022Sep 30, 2022-$9.69M–
Q2 FY2022Jun 30, 2022-$9.19M–
Q1 FY2022Mar 31, 2022-$13.70M–
Q4 FY2021Dec 31, 2021$19.50M–
Q3 FY2021Sep 30, 2021-$16.10M–
Q2 FY2021Jun 30, 2021-$15.93M–
Q1 FY2021Mar 31, 2021-$15.01M–
Q4 FY2020Dec 31, 2020-$8.85M–
Q3 FY2020Sep 30, 2020-$190.57K–
Q2 FY2020Jun 30, 2020-$7.03M–
Q1 FY2020Mar 31, 2020-$9.88M–

More Disc Medicine figures

See a number that looks wrong?